查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2058756

人工智慧平台憂鬱症篩檢市場預測至2034年——全球篩檢方法、交付模式、經營模式、技術堆疊、最終用戶和區域分析

Depression-Screening AI Platforms Market Forecasts to 2034 - Global Analysis By Screening Modality, Delivery Mode, Business Model, Technology Stack, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球憂鬱症篩檢人工智慧平台市場將在 2026 年達到 8 億美元，預計在預測期內將以 10.0% 的複合年成長率成長，到 2034 年達到 18 億美元。

以人工智慧為基礎的憂鬱症篩檢平台利用機器學習和自然語言處理技術，透過使用者互動和數位行為識別憂鬱症的早期症狀。它們評估文字輸入、語氣、臉部徵兆和行為模式，從而識別潛在的心理健康問題。這些系統透過提供初步評估、簡化篩檢流程和促進及時介入來支持臨床醫生。它們通常整合到遠端醫療服務、醫院和員工健康工具中，擴大了心理評估的覆蓋範圍。透過使篩檢更加私密和方便用戶使用，它們減少了社會歧視，提高了用戶參與度。演算法的持續改進提高了檢測準確率，從而增強了它們在全球現代醫療保健系統中的作用。

對 Web of Science 核心合集（2015-2024 年）的文獻計量經濟學分析顯示，有 2304 篇論文涉及人工智慧在憂鬱症診斷中的應用，這表明學術界和臨床界對該領域的興趣正在迅速成長。

憂鬱症和精神疾病盛行率不斷上升

人工智慧平台在憂鬱症篩檢領域的市場擴張主要受全球憂鬱症及相關精神疾病盛行率上升的驅動。現代生活方式帶來的挑戰，例如高壓力、孤獨感和高強度的職場環境，正在加劇各年齡層的心理健康問題。社會歧視和心理健康專業人員的短缺導致許多病例無法接受治療。人工智慧驅動的篩檢工具能夠有效率且擴充性檢測早期症狀，從而快速識別高風險族群。日益加重的心理健康負擔促使醫療服務提供者採用數位解決方案，以支持及時診斷、介入和整體心理健康。

對隱私和資料安全的擔憂

對隱私和敏感資訊保護的擔憂嚴重限制了人工智慧憂鬱症篩檢平台市場的成長。這些系統處理情緒反應、行為模式和心理史等敏感數據，使其容易受到濫用和網路攻擊。任何資料外洩都可能導致嚴重的問題，包括歧視和心理困擾。許多用戶擔心數據被公開，因此對使用這些平台猶豫不決。此外，國際資料保護條例缺乏統一性也使開發人員難以遵守。雖然確保強大的加密、安全的資料管理和符合倫理的使用標準至關重要，但這仍然是阻礙這些人工智慧驅動的篩檢工具更廣泛應用的主要挑戰。

數位心理健康生態系統的擴展

人工智慧憂鬱症篩檢平台市場的關鍵機會在於快速發展的數位心理健康生態系統。遠距遠端醫療服務、心理健康應用程式和虛擬諮詢平台的日益普及，為基於人工智慧的篩檢解決方案奠定了堅實的基礎。這些技術可以無縫整合到數位醫療保健系統中，實現憂鬱症症狀的早期檢測和持續追蹤。對心理健康技術公司的投資增加以及數位醫療保健基礎設施的擴展，進一步推動了市場成長。隨著醫療保健越來越注重預防和遠距醫療，人工智慧驅動的篩檢工具正成為未來全球心理健康管理系統的重要組成部分。

倫理問題和算法偏見

人工智慧憂鬱症篩檢平台市場面臨的主要威脅是倫理問題和演算法偏見。人工智慧模型可能無意中從訓練資料集中繼承偏見，從而導致對不同人群的心理健康評估出現不一致或不公平的結果。這可能會增加誤診和治療結果不平等的風險。此外，人工智慧決策過程透明度不足以及在敏感的心理評估中缺乏人為監督也引發了倫理方面的擔憂。關於不準確預測的責任追究問題進一步損害了公眾信任。這些挑戰削弱了臨床醫生和使用者的信心，最終限制了人工智慧驅動的憂鬱症篩檢解決方案在醫療保健系統中的廣泛應用。

新冠疫情的影響：

新冠疫情加速了數位心理健康技術的普及，從而對憂鬱症篩檢的人工智慧平台市場產生了積極影響。疫情期間，壓力、隔離、失業和不確定性加劇，導致全球憂鬱症盛行率顯著上升，推動了對遠距篩檢解決方案的需求。由於線下醫療服務受限，遠端醫療和基於人工智慧的平台成為心理健康評估的關鍵。醫療機構迅速部署虛擬照護系統，以確保心理支持的連續性。各國政府和機構也擴大了其線上心理健康支持計畫。這段時期凸顯了易於取得、擴充性且技術主導的篩檢工具對於有效應對日益嚴重的心理健康問題的重要性。

在預測期內，數位自評問卷細分市場預計將佔據最大的市場佔有率。

由於其易用性、廣泛的可用性和在各種數位醫療管道中易於實施，預計在預測期內，數位自評問卷將佔據最大的市場佔有率。這些問卷允許個人透過行動應用程式、網站和臨床系統上提供的結構化數位表格來評估自身的心理健康狀況，而無需複雜的技術設定。它們已被醫療服務提供者廣泛接受，用於初步篩檢和識別潛在風險。經濟實惠、擴充性以及能夠容納大規模用戶群是其優勢所在。它們還可作為人工智慧分析的基礎輸入層，支援早期發現和介入。

在預測期內，個人消費者和患者群體預計將呈現最高的複合年成長率。

在預測期內，受心理健康意識提升、智慧型手機普及以及對個人化自我評估數位篩檢工具的強勁需求推動，個人消費者和患者群體預計將呈現最高的成長率。用戶正積極採用行動應用程式和線上平台，以便在無需前往醫療機構的情況下私密地評估自身憂鬱症。社會偏見的減少、可及性的提高以及方便用戶使用的人工智慧介面，都將進一步促進這一成長。與穿戴式科技和個人化回饋系統的整合，增強了使用者參與度。此外，這些解決方案成本低廉且全天候可用，使其極具吸引力，預計將在長期內推動該消費群體的快速擴張。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這得益於其高度發達的醫療保健系統、高數位醫療普及率以及領先的人工智慧和心理健康技術公司的集中分佈。人們對精神疾病的日益關注以及政府對早期發現心理健康問題的支持，都促成了該地區的主導地位。遠距遠端醫療服務的廣泛普及和智慧型手機的高使用率進一步推動了技術的採用率。此外，完善的保險體系和報銷機制也鼓勵醫療服務提供者採用基於人工智慧的篩檢工具，使該地區成為這些技術最先進、最普及的市場。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於技術的快速發展、人們對心理健康問題的日益關注以及數位連接的廣泛普及。印度、中國、日本和韓國等國家正積極致力於透過人工智慧驅動的創新來加強其醫療保健系統。該地區心理健康專業人員的嚴重短缺推動了對便利且經濟高效的篩檢解決方案的需求。政府對遠端醫療和心理健康計劃的支持也進一步促進了這些方案的普及。此外，健康科技新創企業的擴張和行動醫療應用程式的日益普及也推動了全部區域市場的強勁成長。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 應客戶要求，我們提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章：執行摘要

  • 市場概覽及主要亮點
  • 成長動力、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章：全球憂鬱症篩檢人工智慧平台市場：依篩檢方法分類

  • 數位自評問卷
  • 人工智慧驅動的互動式篩檢工具
  • 語音和言語模式分析平台
  • 面部表情和行為分析系統
  • 基於神經認知和生物標記的AI診斷
  • 多模態篩檢平台

第6章：全球憂鬱症篩檢人工智慧平台市場：依交付模式分類

  • 基於行動應用程式的篩檢工具
  • 網路為基礎的篩檢平台
  • 遠端醫療整合篩檢解決方案
  • 院內人工智慧篩檢系統
  • 職場/企業健康篩檢計劃

第7章：全球憂鬱症篩檢人工智慧平台市場：依經營模式分類

  • 訂閱式數位平台
  • 一次性購買篩檢工具包/應用程式
  • 機構許可模式
  • 混合（免費增值+付費）模式

第8章：全球憂鬱症篩檢人工智慧平台市場：按技術堆疊分類

  • 自然語言處理（NLP）引擎
  • 情感與情緒辨識演算法
  • 機器學習與預測分析框架
  • 與電子健康記錄 (EHR) 整合
  • 資料安全和隱私合規模組

第9章 全球人工智慧憂鬱症篩檢平台市場：依最終用戶分類

  • 普通消費者/患者
  • 臨床醫師/治療師
  • 醫院和醫療保健機構
  • 教育機構
  • 企業健康計劃
  • 研究中心

第10章：全球憂鬱症篩檢人工智慧平台市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第11章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第12章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟、合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第13章：公司簡介

  • Woebot Health
  • Wysa Ltd
  • Moodpath
  • Lyra Health, Inc.
  • Spring Care, Inc.（Spring Health）
  • Koa Health
  • Ellipsis Health
  • Cogito
  • Kintsugi Mindful Wellness, Inc.
  • Limbic
  • AiCure
  • Cognito Therapeutics
  • Headspace Health
  • Aiberry
  • Sonde Health, Inc.
  • X2AI
  • Mental Health AI
  • Calmerry
Product Code: SMRC36360

According to Stratistics MRC, the Global Depression-Screening AI Platforms Market is accounted for $0.8 billion in 2026 and is expected to reach $1.8 billion by 2034 growing at a CAGR of 10.0% during the forecast period. AI-based depression screening platforms apply machine learning and natural language processing to recognize early symptoms of depression from user interactions and digital behavior. They evaluate text inputs, speech tone, facial cues, and activity patterns to flag possible mental health concerns. These systems assist clinicians by providing initial assessments, streamlining screening processes, and supporting timely intervention. Commonly integrated into telemedicine services, hospitals, and employee wellness tools, they expand access to psychological evaluation. By making screening more private and user-friendly, they reduce stigma and increase engagement. Ongoing algorithm improvements enhance detection accuracy, strengthening their role in modern healthcare systems across global systems.

According to a bibliometric analysis of the Web of Science Core Collection (2015-2024), there were 2,304 publications on AI applications in depression diagnosis, reflecting rapid growth in academic and clinical interest in this field.

Market Dynamics:

Driver:

Rising prevalence of depression and mental health disorders

The expansion of the Depression-Screening AI Platforms Market is largely fueled by the rising incidence of depression and related psychological conditions worldwide. Modern lifestyle challenges, including high stress levels, isolation, and demanding work environments, have intensified mental health issues across populations. Many cases remain untreated due to social stigma and shortages of mental health professionals. AI-powered screening tools provide efficient, scalable, and early-stage detection of symptoms, enabling faster identification of at-risk individuals. This increasing mental health burden encourages healthcare providers to integrate digital solutions that support timely diagnosis, intervention, and improved overall psychological well-being.

Restraint:

Privacy and data security concerns

Concerns regarding privacy and protection of sensitive information significantly restrict the growth of the Depression-Screening AI Platforms Market. These systems handle confidential data such as emotional responses, behavioral patterns, and psychological history, making them vulnerable to misuse or cyberattacks. Any breach can result in serious issues including discrimination or emotional distress. Many users are reluctant to engage with these platforms due to fear of data exposure. Additionally, inconsistent international data protection regulations complicate compliance for developers. Ensuring strong encryption, secure data management, and ethical usage standards is essential but remains a key challenge hindering broader acceptance of these AI-driven screening tools.

Opportunity:

Expansion of digital mental health ecosystem

A key opportunity for the Depression-Screening AI Platforms Market lies in the fast-growing digital mental health ecosystem. The rising use of telehealth services, mental health applications, and virtual counseling platforms is creating a strong foundation for AI-based screening solutions. These technologies can be seamlessly incorporated into digital healthcare systems to enable early identification and ongoing tracking of depressive symptoms. Increased funding for mental health technology companies and expanding digital healthcare infrastructure are further driving growth. With healthcare increasingly focusing on prevention and remote care delivery, AI-driven screening tools are becoming essential components of future mental health management systems worldwide.

Threat:

Ethical concerns and algorithmic bias

A major threat to the Depression-Screening AI Platforms Market is the presence of ethical issues and algorithmic bias. Artificial intelligence models may unintentionally inherit biases from training datasets, leading to inconsistent or unfair mental health assessments across diverse population groups. This can increase the risk of misdiagnosis or unequal treatment outcomes. Ethical concerns also emerge due to limited transparency in AI decision-making and reduced human supervision in sensitive psychological evaluations. Questions regarding responsibility for incorrect predictions further impact trust. These challenges weaken confidence among clinicians and users, ultimately restricting the broader adoption of AI-driven depression screening solutions in healthcare systems.

Covid-19 Impact:

The COVID-19 pandemic positively influenced the Depression-Screening AI Platforms Market by speeding up the use of digital mental health technologies. Rising stress, isolation, unemployment, and uncertainty during the pandemic significantly increased depression rates worldwide, creating higher demand for remote screening solutions. With limited access to in-person healthcare services, telemedicine and AI-based platforms became essential for mental health evaluation. Healthcare providers rapidly adopted virtual care systems to ensure continuity of psychological support. Governments and institutions also expanded online mental health initiatives. This period emphasized the importance of accessible, scalable, and technology-driven screening tools in managing growing mental health concerns effectively across populations.

The digital self-assessment questionnaires segment is expected to be the largest during the forecast period

The digital self-assessment questionnaires segment is expected to account for the largest market share during the forecast period because they are easy to use, widely accessible, and simple to deploy across various digital healthcare channels. These questionnaires enable individuals to assess their mental health through structured digital forms available on mobile applications, websites, and clinical systems without requiring advanced technical setup. They are commonly accepted by healthcare providers for preliminary screening and identifying potential risks. Their affordability, scalability, and ability to serve large user bases contribute to their dominance. They also act as a basic input layer for AI-driven analysis, supporting early identification and intervention.

The individual consumers & patients segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the individual consumers & patients segment is predicted to witness the highest growth rate because of increasing mental health awareness, widespread smart phone usage, and strong demand for private self-guided digital screening tools. Users are actively adopting mobile apps and online platforms that allow confidential depression assessment without visiting healthcare facilities. Reduced stigma, improved accessibility, and user-friendly AI-based interfaces are further supporting growth. Integration with wearable technologies and personalized feedback systems enhances user engagement. Moreover, low cost and round-the-clock availability make these solutions highly attractive, driving rapid expansion of this consumer-focused segment over time period.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share because of its highly developed healthcare systems, strong digital health adoption, and concentration of major AI and mental health technology companies. Growing awareness of psychological disorders and government support for early mental health detection contribute to regional leadership. Widespread availability of telemedicine services and high usage of smartphones further enhance adoption rates. In addition, supportive insurance frameworks and reimbursement structures encourage healthcare providers to implement AI-based screening tools, making the region the most advanced and widely adopted market for such technologies.

Region with highest CAGR:

Over the forecast period, the Asia-Pacific region is anticipated to exhibit the highest CAGR because of rapid technological advancement, increasing awareness of mental health issues, and widespread growth in digital connectivity. Countries including India, China, Japan, and South Korea are actively enhancing their healthcare systems with AI-based innovations. A significant shortage of mental health professionals in the region is driving demand for accessible and cost-effective screening solutions. Government support for telemedicine and mental wellness initiatives is further boosting adoption. In addition, the expansion of health tech startups and rising use of mobile health apps are fueling strong market growth across Asia-Pacific.

Key players in the market

Some of the key players in Depression-Screening AI Platforms Market include Woebot Health, Wysa Ltd, Moodpath, Lyra Health, Inc., Spring Care, Inc. (Spring Health), Koa Health, Ellipsis Health, Cogito, Kintsugi Mindful Wellness, Inc., Limbic, AiCure, Cognito Therapeutics, Headspace Health, Aiberry, Sonde Health, Inc., X2AI, Mental Health AI and Calmerry.

Key Developments:

In February 2026, Wysa has secured GBP 5.3 Mn to adapt and evaluate an AI mental health tool for adolescent girls in rural India, in partnership with Imperial College London and Indian academic and community organisations. The collaboration, funded by Wellcome, focuses on scaling a clinically validated digital intervention designed to address anxiety and low mood in low-resource settings.

In November 2024, Cogito Capital Partners, a venture capital firm based in Warsaw and New York City, has announced the first close of its second fund, Cogito Fund II, targeting €125 million in total commitments. Cogito Capital Partners prioritize sectors where they can add value in crafting successful growth strategies. Key areas include enterprise software and data analytics, fintech and insurtech, and healthtech.

Screening Modalities Covered:

  • Digital Self-Assessment Questionnaires
  • AI-enabled Conversational Screening Tools
  • Voice & Speech Pattern Analysis Platforms
  • Facial Expression & Behavioral Analytics Systems
  • Neurocognitive & Biomarker-based AI Diagnostics
  • Multimodal Screening Platforms

Delivery Modes Covered:

  • Mobile Application-based Screening Tools
  • Web-based Screening Platforms
  • Telehealth-integrated Screening Solutions
  • In-clinic AI Screening Systems
  • Workplace & Corporate Wellness Screening Programs

Business Models Covered:

  • Subscription-based Digital Platforms
  • One-time Purchase Screening Kits/Apps
  • Institutional Licensing Models
  • Hybrid (Freemium + Premium) Models

Technology Stacks Covered:

  • Natural Language Processing (NLP) Engines
  • Sentiment & Emotion Recognition Algorithms
  • Machine Learning & Predictive Analytics Frameworks
  • Integration with Electronic Health Records (EHR)
  • Data Security & Privacy Compliance Modules

End Users Covered:

  • Individual Consumers & Patients
  • Clinicians & Therapists
  • Hospitals & Healthcare Providers
  • Educational Institutions
  • Corporate Wellness Programs
  • Research Centers

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Depression Screening AI Platforms Market, By Screening Modality

  • 5.1 Digital Self-Assessment Questionnaires
  • 5.2 AI-enabled Conversational Screening Tools
  • 5.3 Voice & Speech Pattern Analysis Platforms
  • 5.4 Facial Expression & Behavioral Analytics Systems
  • 5.5 Neurocognitive & Biomarker-based AI Diagnostics
  • 5.6 Multimodal Screening Platforms

6 Global Depression Screening AI Platforms Market, By Delivery Mode

  • 6.1 Mobile Application-based Screening Tools
  • 6.2 Web-based Screening Platforms
  • 6.3 Telehealth-integrated Screening Solutions
  • 6.4 In-clinic AI Screening Systems
  • 6.5 Workplace & Corporate Wellness Screening Programs

7 Global Depression Screening AI Platforms Market, By Business Model

  • 7.1 Subscription-based Digital Platforms
  • 7.2 One-time Purchase Screening Kits/Apps
  • 7.3 Institutional Licensing Models
  • 7.4 Hybrid (Freemium + Premium) Models

8 Global Depression Screening AI Platforms Market, By Technology Stack

  • 8.1 Natural Language Processing (NLP) Engines
  • 8.2 Sentiment & Emotion Recognition Algorithms
  • 8.3 Machine Learning & Predictive Analytics Frameworks
  • 8.4 Integration with Electronic Health Records (EHR)
  • 8.5 Data Security & Privacy Compliance Modules

9 Global Depression Screening AI Platforms Market, By End User

  • 9.1 Individual Consumers & Patients
  • 9.2 Clinicians & Therapists
  • 9.3 Hospitals & Healthcare Providers
  • 9.4 Educational Institutions
  • 9.5 Corporate Wellness Programs
  • 9.6 Research Centers

10 Global Depression Screening AI Platforms Market, By Geography

  • 10.1 North America
    • 10.1.1 United States
    • 10.1.2 Canada
    • 10.1.3 Mexico
  • 10.2 Europe
    • 10.2.1 United Kingdom
    • 10.2.2 Germany
    • 10.2.3 France
    • 10.2.4 Italy
    • 10.2.5 Spain
    • 10.2.6 Netherlands
    • 10.2.7 Belgium
    • 10.2.8 Sweden
    • 10.2.9 Switzerland
    • 10.2.10 Poland
    • 10.2.11 Rest of Europe
  • 10.3 Asia Pacific
    • 10.3.1 China
    • 10.3.2 Japan
    • 10.3.3 India
    • 10.3.4 South Korea
    • 10.3.5 Australia
    • 10.3.6 Indonesia
    • 10.3.7 Thailand
    • 10.3.8 Malaysia
    • 10.3.9 Singapore
    • 10.3.10 Vietnam
    • 10.3.11 Rest of Asia Pacific
  • 10.4 South America
    • 10.4.1 Brazil
    • 10.4.2 Argentina
    • 10.4.3 Colombia
    • 10.4.4 Chile
    • 10.4.5 Peru
    • 10.4.6 Rest of South America
  • 10.5 Rest of the World (RoW)
    • 10.5.1 Middle East
      • 10.5.1.1 Saudi Arabia
      • 10.5.1.2 United Arab Emirates
      • 10.5.1.3 Qatar
      • 10.5.1.4 Israel
      • 10.5.1.5 Rest of Middle East
    • 10.5.2 Africa
      • 10.5.2.1 South Africa
      • 10.5.2.2 Egypt
      • 10.5.2.3 Morocco
      • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

  • 11.1 Industry Value Network and Supply Chain Assessment
  • 11.2 White-Space and Opportunity Mapping
  • 11.3 Product Evolution and Market Life Cycle Analysis
  • 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

  • 12.1 Mergers and Acquisitions
  • 12.2 Partnerships, Alliances, and Joint Ventures
  • 12.3 New Product Launches and Certifications
  • 12.4 Capacity Expansion and Investments
  • 12.5 Other Strategic Initiatives

13 Company Profiles

  • 13.1 Woebot Health
  • 13.2 Wysa Ltd
  • 13.3 Moodpath
  • 13.4 Lyra Health, Inc.
  • 13.5 Spring Care, Inc. (Spring Health)
  • 13.6 Koa Health
  • 13.7 Ellipsis Health
  • 13.8 Cogito
  • 13.9 Kintsugi Mindful Wellness, Inc.
  • 13.10 Limbic
  • 13.11 AiCure
  • 13.12 Cognito Therapeutics
  • 13.13 Headspace Health
  • 13.14 Aiberry
  • 13.15 Sonde Health, Inc.
  • 13.16 X2AI
  • 13.17 Mental Health AI
  • 13.18 Calmerry

List of Tables

  • Table 1 Global Depression Screening AI Platforms Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Depression Screening AI Platforms Market Outlook, By Screening Modality (2023-2034) ($MN)
  • Table 3 Global Depression Screening AI Platforms Market Outlook, By Digital Self-Assessment Questionnaires (2023-2034) ($MN)
  • Table 4 Global Depression Screening AI Platforms Market Outlook, By AI-enabled Conversational Screening Tools (2023-2034) ($MN)
  • Table 5 Global Depression Screening AI Platforms Market Outlook, By Voice & Speech Pattern Analysis Platforms (2023-2034) ($MN)
  • Table 6 Global Depression Screening AI Platforms Market Outlook, By Facial Expression & Behavioral Analytics Systems (2023-2034) ($MN)
  • Table 7 Global Depression Screening AI Platforms Market Outlook, By Neurocognitive & Biomarker-based AI Diagnostics (2023-2034) ($MN)
  • Table 8 Global Depression Screening AI Platforms Market Outlook, By Multimodal Screening Platforms (2023-2034) ($MN)
  • Table 9 Global Depression Screening AI Platforms Market Outlook, By Delivery Mode (2023-2034) ($MN)
  • Table 10 Global Depression Screening AI Platforms Market Outlook, By Mobile Application-based Screening Tools (2023-2034) ($MN)
  • Table 11 Global Depression Screening AI Platforms Market Outlook, By Web-based Screening Platforms (2023-2034) ($MN)
  • Table 12 Global Depression Screening AI Platforms Market Outlook, By Telehealth-integrated Screening Solutions (2023-2034) ($MN)
  • Table 13 Global Depression Screening AI Platforms Market Outlook, By In-clinic AI Screening Systems (2023-2034) ($MN)
  • Table 14 Global Depression Screening AI Platforms Market Outlook, By Workplace & Corporate Wellness Screening Programs (2023-2034) ($MN)
  • Table 15 Global Depression Screening AI Platforms Market Outlook, By Business Model (2023-2034) ($MN)
  • Table 16 Global Depression Screening AI Platforms Market Outlook, By Subscription-based Digital Platforms (2023-2034) ($MN)
  • Table 17 Global Depression Screening AI Platforms Market Outlook, By One-time Purchase Screening Kits/Apps (2023-2034) ($MN)
  • Table 18 Global Depression Screening AI Platforms Market Outlook, By Institutional Licensing Models (2023-2034) ($MN)
  • Table 19 Global Depression Screening AI Platforms Market Outlook, By Hybrid (Freemium + Premium) Models (2023-2034) ($MN)
  • Table 20 Global Depression Screening AI Platforms Market Outlook, By Technology Stack (2023-2034) ($MN)
  • Table 21 Global Depression Screening AI Platforms Market Outlook, By Natural Language Processing (NLP) Engines (2023-2034) ($MN)
  • Table 22 Global Depression Screening AI Platforms Market Outlook, By Sentiment & Emotion Recognition Algorithms (2023-2034) ($MN)
  • Table 23 Global Depression Screening AI Platforms Market Outlook, By Machine Learning & Predictive Analytics Frameworks (2023-2034) ($MN)
  • Table 24 Global Depression Screening AI Platforms Market Outlook, By Integration with Electronic Health Records (EHR) (2023-2034) ($MN)
  • Table 25 Global Depression Screening AI Platforms Market Outlook, By Data Security & Privacy Compliance Modules (2023-2034) ($MN)
  • Table 26 Global Depression Screening AI Platforms Market Outlook, By End User (2023-2034) ($MN)
  • Table 27 Global Depression Screening AI Platforms Market Outlook, By Individual Consumers & Patients (2023-2034) ($MN)
  • Table 28 Global Depression Screening AI Platforms Market Outlook, By Clinicians & Therapists (2023-2034) ($MN)
  • Table 29 Global Depression Screening AI Platforms Market Outlook, By Hospitals & Healthcare Providers (2023-2034) ($MN)
  • Table 30 Global Depression Screening AI Platforms Market Outlook, By Educational Institutions (2023-2034) ($MN)
  • Table 31 Global Depression Screening AI Platforms Market Outlook, By Corporate Wellness Programs (2023-2034) ($MN)
  • Table 32 Global Depression Screening AI Platforms Market Outlook, By Research Centers (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.